NDRA vs SNPS · P/E 0.0, $2.6M cap vs P/E 63, rev $7.05B
ENDRA Life Sciences Inc (NDRA) versus Synopsys Inc (SNPS) — a side-by-side from cached financials, not a winner call.
ENDRA Life Sciences Inc (NDRA) is a diagnostics & research company listed on US.
Synopsys Inc (SNPS) is a software - infrastructure company listed on US.
NDRA does not have a complete income-statement cache yet.
Latest reported SNPS revenue for 2025-10-31 was $7.05B. Net income was $1.33B. Revenue was up 15.1% from 2024-10-31 to 2025-10-31. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
NDRA currently screens at market cap $2.6M and trailing P/E 0.0. SNPS currently screens at market cap $85.14B and trailing P/E 63.3.
Not investment advice. Open the NDRA and SNPS stock pages for the full models.
Not investment advice.